TP53 and neoplasm: Our results suggest that histone H3K27M mutations arise first and are associated with specific, obligate partners involving alterations in TP53 cell-cycle (TP53/PPM1D) or specific growth factor pathways (ACVR1/PIK3R1), which are present throughout the tumour as well as its spread outside the brainstem.